ArticleOncotarget2018

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells.

David W Wolff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.